Maravai LifeSciences Holdings (MRVI) Financial Statements & Analysis

Maravai LifeSciences Holdings (MRVI) Income Statement

Maravai LifeSciences Holdings reported revenue of $185.74M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 28.3% from $259.19M a year earlier. Maravai LifeSciences Holdings posted a net loss of $130.77M, compared with a net loss of $144.85M a year earlier. Gross margin was 18.0% and operating margin -3.6%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $51.44M, up 8.5% from the same quarter a year earlier.

Maravai LifeSciences Holdings Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Maravai LifeSciences Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	185.74	259.19	288.95	883.00	799.24	284.10	143.14	123.83
Cost of Revenue	152.35	150.88	148.74	168.96	140.56	79.65	66.85	60.77
Gross Profit	33.39	108.31	140.20	714.04	658.68	204.45	76.29	63.07
Operating Expenses
Research & Development	23.33	19.22	17.28	18.37	15.22	9.30	3.63	4.50
Selling, General & Administrative	171.47	161.77	151.39	125.76	100.06	94.25	48.35	41.19
Operating Expenses	40.13	343.93	171.85	139.83	104.03	84.55	52.30	45.69
Operating Income	-6.74	-235.62	-31.65	574.22	554.65	119.90	23.99	16.44
Other Income/Expense
Interest Income	23.95	27.40	27.73	2.34	0.00	0.00	0.00	0.00
Interest Expense	26.99	-47.70	45.89	-20.41	30.26	30.74	29.96	27.40
Other Income/Expense	-228.24	-25.87	649.38	-22.74	-23.88	-38.21	-29.84	-32.93
Income
Income Before Tax	-234.97	-261.48	617.74	551.47	530.77	81.70	-5.85	-16.50
Income Tax Expense	-4.21	-1.86	756.11	60.81	61.52	2.88	-0.65	0.42
Net Income	-130.77	-144.85	-119.03	220.21	182.04	76.89	-8.49	-17.73
Net Income - Continuous Operations	-130.77	-144.85	-119.03	220.21	182.04	76.89	-8.49	-17.73
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	-147.11	-24.30	712.41	601.75	585.78	138.27	48.19	33.25
EBIT	-125.63	-72.68	663.63	569.92	561.03	103.78	-	-
Depreciation & Amortization	60.87	48.38	48.78	31.84	24.75	25.84	24.08	22.35
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	2.00	2.00	7.00	-	-
Diluted EPS	-1.00	-1.00	-1.00	2.00	2.00	2.00	-	-
Basic Shares Outstanding	145.07	137.91	131.92	131.55	114.79	96.65	96.65	88.97
Diluted Shares Outstanding	145.07	137.91	131.92	255.32	121.97	96.65	96.65	88.97

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Maravai LifeSciences Holdings Financial Statements

What was Maravai LifeSciences Holdings's revenue in fiscal 2025?

Maravai LifeSciences Holdings reported revenue of $185.74M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 28.3% from $259.19M a year earlier.

Is Maravai LifeSciences Holdings profitable?

No. Maravai LifeSciences Holdings reported a net loss of $130.77M in fiscal 2025. In fiscal 2024 it lost $144.85M.

What is Maravai LifeSciences Holdings's operating margin?

Maravai LifeSciences Holdings's operating income was −$6.74M on revenue of $185.74M in fiscal 2025, an operating margin of -3.6%, compared with -90.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition